Matricelf (Matricelf) Total Equity : $0.00 Mil (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is Matricelf Total Equity?

Matricelf's total equity for the quarter that ended in . 20 was $0.00 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Matricelf Total Equity Historical Data

The historical data trend for Matricelf's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Matricelf Total Equity Chart

Matricelf Annual Data

Trend

Total Equity

Matricelf Semi-Annual Data

Total Equity

Matricelf Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Matricelf's Total Equity for the fiscal year that ended in . 20 is calculated as

Total Equity	=	Total Assets(Q: . 20 )	-	Total Liabilities(Q: . 20 )
	=	N/A	-	N/A
	=	N/A

Matricelf's Total Equity for the quarter that ended in . 20 is calculated as

Total Equity	=	Total Assets(Q: . 20 )	-	Total Liabilities(Q: . 20 )
	=	N/A	-	N/A
	=	N/A

Matricelf Total Equity Related Terms

Thank you for viewing the detailed overview of Matricelf's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Matricelf (Matricelf) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matricelf Ltd (OTCPK:MTRLF) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

MTLF:Israel

Address

Golda Meir 3, Ness Ziona, ISR, 6701838

Website

https://www.matricelf.com

Matricelf Ltd is engaged in research and development in the field of medicine and tissue engineering. It is a pioneering biotechnology company developing a platform for autologous matrix and cells implants for a wide range of medical conditions.

Matricelf (Matricelf) Headlines

From GuruFocus

Matricelf technology in treating paralysis due to chronic spinal cord injury in mice with the world's first 3D engineered neural tissue implant

By PRNewswire PRNewswire • 02-07-2022

Matricelf has reached a major milestone

By PRNewswire PRNewswire • 05-02-2022